Type 1 Diabetes TrialNet. Researchers conducting this study are Diabetes study will help us learn more about. a dietary substance called docosahexaenoic …
Background
Type 1 diabetes is an autoimmune disease which generally begins during childhood It occurs when the immune system — there to help your body fight infection — mistakenly attacks your insulin-producing cells When these cells are destroyed, your body can no longer make insulin This is how type 1 diabetes happens The Nutritional Intervention to Prevent Type 1 Diabetes study will help us learn more about a dietary substance called docosahexaenoic acid DHA, an Omega-3 fatty acid DHA is a natural ingredient found in a mothers breast milk and in various foods It may be important to the growth of a healthy baby This research is being done as a pilot study, which is a test run to find out if it is possible to do a larger study
Type 1 Diabetes TrialNet
Researchers conducting this study are part of a larger group called Type I Diabetes TrialNet, an international network of centers dedicated to the study, prevention, and early treatment of type 1 diabetes To learn more about this study or other TrialNet studies, call toll free 1-800-HALT-DM1 1-800-425-8361 You can also learn more at
Nutritional Intervention to Prevent NIP Diabetes
wwwdiabetestrialnetorg
All shared information
will remain confidential
TrialNet Sponsors
National Institute of Diabetes Digestive Kidney Diseases
Who can participate
Pregnant women in their 3rd trimester more than 24 weeks may enroll in the study if the baby they are expecting has a relative mother, father, sister, brother, half-sister, or half-brother with type 1 diabetes Babies up to five months old may also be enrolled in the study if they have a relative with type 1 diabetes
NATIONAL INSTITUTES OF HEALTH
National Institute of Allergy and Infectious Diseases
NATIONAL INSTITUTES OF HEALTH
A Research Study for Infants at Increased Risk for Type 1 Diabetes
Babies will require a blood test to determine eligibility
October 2006
What does participating involve
If pregnant, you will take four capsules a day during 
your third trimester If nursing, you will also be asked to take four capsules a day The capsules will contain either DHA or an ingredient that does nothing at all called a placebo Neither you nor the study staff will know if you are taking the capsules with DHA or the capsules with placebo If your baby is on infant formula, you will be asked to use formula provided by the study All study formula will
contain some DHA You and your baby will need to make regular visits to the study site We will collect a sample of your babys blood We will ask about your babys diet and yours if you are pregnant or nursing If you are nursing, you will need to bring in a sample of your breast milk We will also ask other health questions It is anticipated that babies will participate in the study for at least one year
Nutritional Intervention to Prevent Type 1 Diabetes For more information, contact one of the participating centers:
California Childrens Hospital Los Angeles Los Angeles, CA 888 835-3761 Childrens Hospital of Orange County Orange, CA 714 532-8613 or 714 532-8642 University of California, San Francisco San Francisco, CA 415 502-8640 Indiana Indiana University Riley Hospital for Children Indianapolis, IN 866 230-8486 Iowa University of Iowa Childrens Hospital of Iowa Iowa City, IA 866 309-0837 Massachusetts Joslin Diabetes Center Beth Israel Deaconess Medical Center Boston, MA 617 732-2647 Minnesota University of Minnesota Minneapolis, MN 612 625-7931 Missouri The Childrens Mercy Hospital Kansas City, MO 816 983-6529 Utah University of Utah Utah Diabetes Center Salt Lake City, UT 801
587-3972
Why participate
You might learn whether your baby is at risk for getting type 1 diabetes If this study is successful, your baby might become part of a larger study to determine if type 1 diabetes may be prevented You and your baby will be contributing to diabetes research
Source:diabetestrialnet.org
